科順股份(300737.SZ):深中通道工程選用了公司生產的噴塗聚脲防水塗料、預鋪高分子防水卷材和水泥基滲透結晶型防水塗料
格隆匯7月1日丨科順股份(300737.SZ)在投資者互動平台表示,深中通道作為粵港澳大灣區的一項超級工程,它不僅連接了珠江口的東西兩岸,而且是目前世界上綜合建設難度最高的跨海集羣工程之一。我們公司很榮幸能夠參與到這項世界級的超級工程中來。在高温、高鹽、高濕的海洋環境中,對防水材料的性能要求極為嚴格,特別是強度、耐腐蝕性和耐疲勞性。為了應對基坑滲水壓力、地下水浸泡腐蝕以及海洋生態保護等技術挑戰,項目選用了公司生產的噴塗聚脲防水塗料、預鋪高分子防水卷材和水泥基滲透結晶型防水塗料等環保產品,以確保工程的質量和環境的可持續性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.